CSIMarket
 
China Pharma Holdings Inc   (CPHI)
Other Ticker:  
 

China Pharma Holdings Inc

Business Description


China Pharma Holdings Inc. (CPHI) is a specialty pharmaceutical company based in China. The company primarily focuses on the research, development, manufacturing, marketing, and distribution of a wide range of pharmaceutical products.

CPHI operates through its wholly-owned subsidiaries, primarily Shandong Boan Biological Products Co., Ltd. and Jilin Hengshan Jinyang Pharmaceutical Co., Ltd. These subsidiaries are involved in the manufacturing and sale of generic and branded drugs, bio-chemical medicines, and active pharmaceutical ingredients (APIs). The company*s manufacturing facilities are located in China and are compliant with the Good Manufacturing Practice (GMP) standards.

Some of the key therapeutic areas covered by the company*s product portfolio include cardiovascular, central nervous system, anti-infection, and respiratory diseases. Additionally, CPHI also produces various biopharmaceutical products, such as vaccines, immune regulants, and diagnostic reagents.

The company*s extensive research and development capabilities enable it to introduce new products and improve existing ones. CPHI has a team of experienced scientists and researchers who work on developing innovative pharmaceutical formulas and processes. They also collaborate with external research institutes and universities to enhance their R&D capabilities.

In terms of market expansion, CPHI has a strong presence in China, where it operates a robust sales and distribution network. The company also exports its products to various international markets, including the United States, Africa, Asia, and Europe. It leverages its international connections to form partnerships and establish strong distribution channels in these regions.

CPHI places a strong emphasis on quality control and assurance. It adheres to strict quality standards to ensure the safety and effectiveness of its products. The company has received several certifications and accreditations, including the ISO9001:2000 certification for quality management systems.

As a publicly-traded company, CPHI is listed on the NYSE American exchange under the ticker symbol CPHI. The company regularly reports its financial performance, which provides transparency to its shareholders and potential investors.

In summary, China Pharma Holdings Inc. is a specialized pharmaceutical company in China, known for its research, development, manufacturing, and distribution of a wide range of pharmaceutical products. It focuses on various therapeutic areas, has a strong sales and distribution network, and places a high emphasis on quality control.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com